U.S. Study Reveals Nearly 2 Million Excess Deaths in China Post ‘Zero-Covid.
A recent U.S. study has unveiled a stark contrast to the official figures provided by Beijing regarding the aftermath of China’s decision to lift its “zero-Covid” restrictions.
The study, conducted by the Fred Hutchinson Cancer Center in Seattle and published on Thursday, indicates that there were nearly 2 million excess deaths in the two months following the lifting of these restrictions. This revelation challenges the accuracy of the official data, which has been criticized for downplaying the extent of the impact.
The researchers delved into the data and estimated that between December 2022 and January, there were approximately 1.87 million excess deaths from all causes among individuals aged 30 and above.
Strikingly, these excess deaths were observed across mainland Chinese provinces, excluding Tibet, and were prominently concentrated among the elderly population.
China’s rigorous “zero-Covid” measures had effectively curbed the spread of the virus and kept both Covid cases and fatalities at bay for a significant portion of the pandemic. These measures encompassed widespread testing, stringent border closures, and extended city lockdowns.
However, the landscape dramatically changed in December when the Chinese government suddenly decided to lift these restrictions, following unusual mass protests that had sprung up across the nation. The consequence of this decision was the sudden exposure of a population of 1.4 billion to a virus that had been suppressed mainly until then.
This transition triggered a devastating surge in Covid cases, primarily driven by the highly transmissible omicron variant. This surge was accompanied by a notable rise in hospitalizations and deaths, aspects that experts argue were not accurately represented in official reports.
They cite both anecdotal evidence and satellite imagery illustrating heightened activity at crematoriums and funeral homes as indicators of the magnitude of the crisis.
The staggering 1.87 million excess deaths starkly contradicts the statistics provided by the Chinese government. Official data stated that around 60,000 deaths related to COVID-19 had been recorded within healthcare facilities from early December 2022 to January 12.
The disparity between the research findings and official figures raises significant concerns about transparency and accountability in reporting the impact of policy decisions.
These findings also align with estimates made by other researchers. Notably, a separate study by Zhanwei Du of the University of Hong Kong and Lauren Ancel Meyers of the University of Texas at Austin indicated that Covid-related fatalities might have exceeded 1.4 million individuals in China between December 16, 2022, and January 19.
In conclusion, the aftermath of China’s decision to lift its “zero-Covid” restrictions has been brought into sharper focus by the recent U.S. study. The revelation of nearly 2 million excess deaths within two months of the policy shift challenges the officially reported figures and underscores the potential underreporting of the pandemic’s toll.
This study sheds light on the gravity of the situation and highlights the importance of accurate and transparent data reporting in understanding the consequences of policy choices.
Compared to the United States, where Covid-related deaths have exceeded 1.1 million since the pandemic’s onset, China has officially reported a significantly lower figure of under 122,000 Covid-related deaths to the World Health Organization. This considerable discrepancy in reported fatalities has drawn attention to the accuracy and transparency of data disclosure.
Chinese authorities have not deliberately withheld Covid-related data from the global community. They counter accuse the United States, the World Health Organization, and other entities of politicizing the pandemic for their agendas.
Despite external skepticism, Chinese officials assert they are actively analyzing excess mortality figures. They anticipate that these efforts will culminate in a more comprehensive and accurate assessment of the Covid death toll, although the timeline remains uncertain.
Interestingly, attempts to seek clarity from China’s National Health Commission regarding these matters have yet to respond, underscoring the challenges in obtaining transparent information on the issue.
As the disparity between reported COVID-related deaths in China and other parts of the world continues to raise questions, the differing narratives around data accuracy and information sharing highlight the complexities of managing a global crisis.
The discrepancies also emphasize the importance of open collaboration among nations and international organizations to ensure reliable and comprehensive data dissemination, fostering a better understanding of the pandemic’s true impact.
